Literature DB >> 23250376

[Legal and sanitary aspects conditioning access to medicines in Brazilian courts].

Mércia Pandolfo1, Maria Célia Delduque, Rita Goreti Amaral.   

Abstract

The search for having access to health care and medicines right granted through Judicial Courts has increased in Brazil. What has been nominated "health judicialization" is a multidimensional phenomenon, a need for dealing with it in a multidisciplinary way involving legal-judicial, political-institutional and sanitary approaches has raised. The Health is recognized as a fundamental human right in the Brazilian Constitution giving it a different legal protection under the legal-constitutional order and the country guarantees the right to health are not only the Constitution and the law strictly, but mainly in an normative infralegal arc that define the goals and outcomes to be achieved by public policy. The lawsuits by drugs may be a reflection of the difficulty of access to health services, to empty and downgrading of health care. Therefore, this turns out to affect the judicialization of pharmaceutical care in Brazil.

Entities:  

Mesh:

Year:  2012        PMID: 23250376     DOI: 10.1590/s0124-00642012000200014

Source DB:  PubMed          Journal:  Rev Salud Publica (Bogota)        ISSN: 0124-0064


  2 in total

1.  Profile of judicialization in access to antineoplastic drugs and their costs: a cross-sectional, descriptive study based on a set of all lawsuits filed between 2016 and 2018 in a state in the Northeast Region of Brazil.

Authors:  Fábio Henrique Cavalcanti de Oliveira; José Eudes de Lorena Sobrinho; Antônio da Cruz Gouveia Mendes; Haynne Magalhães Santos Gutman; Geraldo Jorge Filho; Ulisses Ramos Montarroyos
Journal:  BMC Public Health       Date:  2022-09-26       Impact factor: 4.135

2.  Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil.

Authors:  Virginia Oliveira Chagas; Mércia Pandolfo Provin; Pedro Augusto Prado Mota; Rafael Alves Guimarães; Rita Goreti Amaral
Journal:  BMC Health Serv Res       Date:  2020-02-03       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.